IMIDeology
IMIDeology is a clinician-led autoimmune research network that connects practicing specialists with diverse patient communities to make clinical trials more inclusive, accessible, and effective. The network spans rheumatology, gastroenterology, and dermatology, covering conditions like psoriatic arthritis, Crohn’s disease, and psoriasis. By uniting real-world clinical expertise with patient-centered recruitment, the company aims to improve trial retention and generate insights that reflect actual autoimmune care.
- Healthcare Technology
- Software Only
Funding
Founders
Product
Problem
Autoimmune clinical trials often struggle with low patient diversity, poor retention, and limited access to research opportunities, particularly for patients outside major academic centers. This leads to study results that may not accurately represent real-world autoimmune populations, slowing the development of effective therapies.
Solution
IMIDeology is a clinician-led autoimmune research network that partners with practicing specialists across rheumatology, gastroenterology, and dermatology to make trials more inclusive and accessible. The network leverages its clinicians' direct patient relationships to expand recruitment into diverse community settings, improving enrollment and retention. By embedding research into routine clinical care, IMIDeology generates real-world insights that better reflect how autoimmune conditions present and respond to treatment across different populations. The company also collaborates on AI studies and registry oversight to advance disease understanding and therapeutic development.
Target Audience
Primary customers are pharmaceutical companies, contract research organizations, and academic institutions seeking to run autoimmune clinical trials with improved patient diversity, enrollment speed, and retention.
Features
- Multi-specialty network covering rheumatology, gastroenterology, and dermatology for autoimmune and inflammatory conditions
- Direct access to practicing clinicians who can identify and enroll eligible patients during routine visits
- Focus on diverse and underserved patient communities to improve trial representativeness
- Collaboration on AI-based research initiatives and disease registries to support longitudinal data collection
- Clinician-led governance ensuring study designs align with real-world clinical practice